Equities

ValiRx PLC

VAL:LSE

ValiRx PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.345
  • Today's Change0.0000000000000001 / 0.00%
  • Shares traded478.62k
  • 1 Year change-52.41%
  • Beta-1.0654
Data delayed at least 20 minutes, as of Feb 06 2026 15:39 GMT.
More ▼

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2024, ValiRx PLC increased its cash reserves by 790.77%, or 1.38m. Cash Flow from Financing totalled 3.00m or 6,035.19% of revenues. In addition the company used 1.58m for operations while cash used for investing totalled 38.16k.
Cash flow per share-0.0064
Price/Cash flow per share--
Book value per share0.0092
Tangible book value per share0.0037
More ▼

Balance sheet in GBPView more

ValiRx PLC uses little debt in its capital structure as supported by a debt to capital ratio of 0.22%.
Current ratio9.66
Quick ratio8.87
Total debt/total equity0.0019
Total debt/total capital0.0022
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.